With a surge in new cases surpassing daily highs across the US, it is clear that the battle against COVID-19 will continue for the foreseeable future. While much of the world tries to go back to “normal”, healthcare workers on …

Over the past several weeks, we have seen a number of provinces and states relax restrictions and open up further. Combined with the start of summer, this has caused many to ease on social distancing measures some more so than …

As a leader in the Canadian life science investment community, Lumira Ventures has been closely monitoring and engaging with companies who are developing COVID-19 treatments and vaccines. While our portfolio companies and employees within have been significantly impacted by the …

This week, Lumira Ventures is proud to have supported five additional high impact COVID-19 initiatives as part of our Double Bottom Line Challenge While some provinces and states are gradually beginning to reopen, unfortunately the magnitude and reach of the …

At Lumira Ventures, the past couple of months have been consumed with evaluating new investment opportunities, and working with our portfolio companies, governments, and the venture and healthcare ecosystems to ensure that our companies and all innovation-centric companies broadly are …

The Canadian Venture Capital Association interview between CVCA CEO, Mike Woollatt and Peter van der Velden, Managing General Partner, Lumira Capital. Learn more here.

The Research Institute of St. Joe’s Hamilton is set to receive philanthropic funding from Lumira Capital to support research initiatives at the hospital. Lumira Capital – a leading North American healthcare venture capital firm – has launched a new philanthropic …

Lumira Partners donate a portion of their profits to support foundations’ research, translational medicine and healthcare access missions. Affiliated foundation institutions gain access to Lumira Capital team and extended network to accelerate their innovation strategies. TORONTO, June 6, 2017 /CNW/ – …